United Therapeutics Corporation Announces FDA Filing Acceptance Of New Drug Application For Ralinepag
UTHR•FDA accepts new drug application for ralinepag
Aug. 24 (Reuters) - United Therapeutics Corporation UTHR.O:
- United Therapeutics Corporation announces FDA filing acceptance of new drug application for ralinepag to treat pulmonary arterial hypertension
- United Therapeutics Corporation - FDA sets PDUFA target action date for ralinepag on June 24, 2027
- United Therapeutics Corporation: ralinepag has not been approved for use in any indication by FDA and remains investigational for PAH
